BiotechTube
Home/Candel Therapeutics/Paul Peter Tak
PP

Paul Peter Tak

President and Chief Executive Officer

Candel Therapeutics

Therapeutic Areas

Oncology

Candel Therapeutics Pipeline

DrugIndicationPhase
CAN-2409Non-Small Cell Lung Cancer (NSCLC)Phase 3
CAN-3110Recurrent High-Grade GliomaPhase 1

Leadership Team at Candel Therapeutics

FG
Francesco G. Marincola
Chief Scientific Officer
JA
Jason Amello
Chief Financial Officer
GT
Gary Temple
Chief Development Officer
RM
Ronald Martell
Chairman of the Board
View full Candel Therapeutics profile